CoChat

Preclinical Testing in the Development of Probiotics: A Regulatory Perspective with Bacillus Strains as an Example

Sorokulova, Iryna · 2008 · Clinical Infectious Diseases

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Preclinical testing of the microbial strains is the first important step in the development of probiotics. Requirements for the set of tests can vary depending on the bacterial species and the expected mechanism of action in the organism. Common approaches to preclinical testing of probiotic strains include strain identification (i.e., determination of phenotypic and genotypic properties), safety evaluation (i.e., characterization of history of use [safety contact], assessment of resistance to antibiotics, and evaluation of pathogenic properties in vitro and in animal models), and efficacy testing (i.e., functional characterization). Future progress in probiotics requires more studies to determine the mechanisms of their action, as well as an understanding of the basis and mechanisms of pathogenicity for different probiotic strains. Special attention should be given to recombinant probiotics, particularly in the formulation of criteria for selection of the host strain, for assessment of environmental safety, and for tracing the fate of recombinant DNA in vitro and in vivo.

Overview

Integrity signals

Registry

Crossref · 10.1086/523334

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 8

  1. Smirnov VV, 1994, Antibiot Khimioter, 39, 23
  2. Donohue DC, 2006, Asia Pac J Clin Nutr, 15, 563
  3. Osipova IG, 1998, Zh Mikrobiol Epidemiol Immunobiol, 6, 68
  4. Momose H, 1979, Appl Pharmacol, 17, 881
  5. Urdaci MC, 2004, United Kingdom: Horizon Bioscience, 171
  6. Sorokulova IB, 1997, Mikrobiol Z, 59, 43
  7. Furzikova TM, 2000, Mikrobiol Z, 62, 26
  8. Sorokulova IB, 1997, Vestn Ross Akad Med Nauk, 3, 46

Cited by

See all 38

Metadata

Authors
Sorokulova, I.
Affiliations
National Academy of Sciences of Ukraine (UA)
Corresponding author
Sorokulova, Iryna
Venue
Clinical Infectious Diseases
Published
2008-02
Volume
46
Issue
s2
Pages
S92-S95
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2119190439
Cited by
38
References
35
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 6
FWCI
2.13
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
General Mills
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
Keywords
probiotics, preclinical testing, regulatory requirements, strain identification, safety assessment, antibiotic resistance, pathogenicity, efficacy evaluation, recombinant probiotics, host strain selection, environmental safety, mechanism of action
MeSH terms
Animals, Bacillus, Bacteria, Consumer Product Safety, Drug Evaluation, Preclinical, Humans, Probiotics, Drug Resistance, Bacterial, Government Regulation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.